Publikationen

PubMed

Global Burden of Major Chronic Liver Diseases in 2021.
Feng G, Yilmaz Y, Valenti L, Seto WK, Pan CQ, Méndez-Sánchez N, Ye F, Sookoian S, Targher G, Byrne CD, Chan WK, Treeprasertsuk S, Yu HH, Kim SU, George J, Xu WJ, Sebastiani G, Ocama P, Ryan JD, Lupșor-Platon M, Ghazinyan H, Hamid S, Perera N, Alswat K, Isakov V, Pan Q, Sarin SK, Schattenberg JM, Sotoudeheian M, Wong YJ, Sharara AI, Al-Busafi SA, Opio CK, Chai J, Fouad Y, Shi Y, Al-Mahtab M, Zhang S, Pirola CJ, Wong VW, Zheng MH.
Liver Int. 2025 Apr;45(4):e70058.
PMID: 40062742

Prevalence of Retinal Vascular Anomalies in the German Population: Results from the Gutenberg Health Study.
Voigt AM, Neubert K, Hoh S, Haj Ibrahim A, Wild PS, Lackner KJ, Wicke FS, Schmidtmann I, Münzel T, Tüscher O, Schattenberg JM, Konstantinides SV, Pfeiffer N, Schuster AK.
Ophthalmic Epidemiol. 2025 Mar 4:1-8.
PMID: 40036695

Hot and Cold Fibrosis: The Role of Serum Biomarkers to assess the Immune Mechanisms and ECM-Cell Interactions in Human Fibrosis.
Zawadzki A, Leeming DJ, Sanyal AJ, Anstee QM, Schattenberg JM, Friedman SL, Schuppan SD, Karsdal MA.
J Hepatol. 2025 Mar 6:S0168-8278(25)00148-5.
PMID: 40056933

Collagen turnover biomarkers to predict outcome of patients with biliary cancer.
Kaps L, Genc MA, Moehler M, Grabbe S, Schattenberg JM, Schuppan D, Pedersen RS, Karsdal MA, Mildenberger P, Maderer A, Willumsen N.
BMC Gastroenterol. 2025 Feb 4;25(1):53.
PMID: 39905306

Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD.
Vali Y, van Dijk AM, Lee J, Boursier J, Ratziu V, Yunis C, Schattenberg JM, Valenti L, Gomez MR, Schuppan D, Petta S, Allison M, Hartman ML, Porthan K, Dufour JF, Bugianesi E, Gastadelli A, Derdak Z, Fournier-Poizat C, Shumbayawonda E, Kalutkiewicz M, Yki-Jarvinen H, Ekstedt M, Geier A, Trylesinski A, Francque S, Brass C, Pavlides M, Holleboom AG, Nieuwdorp M, Anstee QM, Bossuyt PM; LITMUS investigators.
Liver Int. 2025 Feb;45(2):e16240.
PMID: 39865358

Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort study.
Boeckmans J, Widman L, Shang Y, Strandberg R, Wester A, Schattenberg JM, Hagström H.
Eur J Intern Med. 2025 Feb 13:S0953-6205(25)00055-X.
PMID: 39952814

Revolutionizing MASLD: How Artificial Intelligence Is Shaping the Future of Liver Care.
Pugliese N, Bertazzoni A, Hassan C, Schattenberg JM, Aghemo A.
Cancers (Basel). 2025 Feb 20;17(5):722.
PMID: 40075570

Gender-specific changes in vision-related quality of life over time - results from the population-based Gutenberg Health Study.
Hartmann A, Grabitz SD, Wild PS, Lackner KJ, Münzel T, Kerahrodi JG, Singer S, Geschke K, Schattenberg JM, Konstantinides S, Pfeiffer N, Schuster AK.
Graefes Arch Clin Exp Ophthalmol. 2025 Feb 11.
PMID: 39934353

Incidence of retinal vein occlusion and its association with mortality - results from the Gutenberg Health Study.
Voigt AM, Elbaz H, Böhm EW, Wild PS, Lackner KJ, Beutel ME, Schmidtmann I, Tu Scher O, Schattenberg JM, Konstantinides SV, Pfeiffer N, Peto T, Schuster AK.
Ophthalmology. 2025 Feb 17:S0161-6420(25)00126-5
PMID: 39971137

Is curcumin the new kid on the block for the treatment of MASH?
Zelber-Sagi S, Schattenberg JM.
Hepatology. 2025 Feb 1;81(2):399-401.
PMID: 38937942

A European Survey to Identify Challenges in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.
Castera L, Alazawi W, Bugianesi E, Caussy C, Federici M, Romero-Gómez M, Schattenberg JM, Basuroy R, Prasad P, Estulin D, Lazarus JV.
Liver Int. 2025 Feb;45(2):e16224.
PMID: 39752213

Tinnitus is not associated with cardiovascular risk factors or mortality in the Gutenberg Health Study.
Hahad O, Hackenberg B, Döge J, Bahr-Hamm K, Kerahrodi JG, Tüscher O, Michal M, Kontohow-Beckers K, Schuster AK, Schmidtmann I, Lackner KJ, Schattenberg JM, Konstantinides S, Wild PS, Münzel T.
Clin Res Cardiol. 2025 Feb 19.
PMID: 39969565

Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle Formulations.
Karatayli E, Sadiq SC, Schattenberg JM, Grabbe S, Biersack B, Kaps L.
Cancers (Basel). 2025 Feb 1;17(3):484.
PMID: 39941855

Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective.
Younossi ZM, Razavi H, Sherman M, Allen AM, Anstee QM, Cusi K, Friedman SL, Lawitz E, Lazarus JV, Schuppan D, Romero-Gómez M, Schattenberg JM, Vos MB, Wong VW, Ratziu V, Hompesch M, Sanyal AJ, Loomba R.
Aliment Pharmacol Ther. 2025 Feb 18.
PMID: 39967239

A family with gallstone disease: defining inherited risk in the era of clinical genetic testing.
Weber SN, Lambert I, Lammert F, Krawczyk M.
Intern Emerg Med. 2025 Jan 9.
PMID: 39786488

Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study.
Lindvig KP, Thorhauge KH, Hansen JK, Kjærgaard M, Hansen CD, Johansen S, Lyngbeck E, Israelsen M, Andersen P, Bech KT, Torp N, Schnefeld HL, Detlefsen S, Möller S, Graupera I, Trelle MB, Antonsen S, Harris R, Kårhus LL, Bjørnsbo KS, Brøns C, Hansen T, Geier A, Wedemeyer H, Zeuzem S, Schattenberg JM, Ginès P, Guha IN, Krag A, Thiele M.
Lancet Gastroenterol Hepatol. 2025 Jan;10(1):55-67.
PMID: 39674225

Short Report - Birth Weight is Not Associated With Cataracts or Pseudophakia - Results from the Gutenberg Health Study.
Fieß A, Gißler S, Grabitz S, Wild PS, Lackner KJ, Beutel ME, Urschitz MS, Tüscher O, Münzel T, Schattenberg JM, Konstantinides SV, Pfeiffer N, Schuster AK.
Clin Ophthalmol. 2025 Jan 16;19:153-156.
PMID: 39834533

A machine learning based algorithm accurately stages liver disease by quantification of arteries.
Li Z, Sun X, Zhao Z, Yang Q, Ren Y, Teng X, Tai DCS, Wanless IR, Schattenberg JM, Liu C.
Sci Rep. 2025 Jan 24;15(1):3143.
PMID: 39856155

Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021.
Wu C, Targher G, Byrne CD, Mao Y, Cheung TT, Yilmaz Y, Valenti L, Méndez-Sánchez N, Sookoian S, Chan WK, Treeprasertsuk S, Yu HH, Kim SU, George J, Hu D, Sebastiani G, Ryan JD, Oviedo RJ, Zhong JH, Schattenberg JM, Lonardo A, Ruiz-Úcar E, Seto WK, Sotoudeheian M, Ocama P, Lupşor-Platon M, Yang T, Ghazinyan H, Pan Q, Hamid S, Adams L, Chai J, Prasad A, Perera N, Alswat K, Isakov V, Sarin SK, Sharara AI, Sanai FM, Al-Busafi SA, Opio CK, Toro-Huamanchumo CJ, Yang W, Wong YJ, Torzilli G, Fouad Y, Zheng MH.
Am J Gastroenterol. 2025 Jan 3.
PMID: 39749919

[Arthropathy as the first manifestation of undiagnosed hemochromatosis: a case report on an unusual course].
Besjana H, Schattenberg JM, Triantafyllias K.
Dtsch Med Wochenschr. 2025 Jan;150(3):101-105.
PMID: 39809433

A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing.
Benderski K, Schneider P, Kordeves P, Fichter M, Schunke J, De Lorenzi F, Durak F, Schrörs B, Akilli Ö, Kiessling F, Bros M, Diken M, Grabbe S, Schattenberg JM, Lammers T, Sofias AM, Kaps L.
Pharmacol Res. 2025 Jan;211:107560.
PMID: 39730106

Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study.
Jachs M, Odriozola A, Turon F, Moga L, Téllez L, Fischer P, Saltini D, Kwanten WJ, Grasso M, Llop E, Mendoza YP, Armandi A, Thalhammer J, Pardo C, Colecchia A, Ravaioli F, Maasoumy B, Laleman W, Presa J, Schattenberg JM, Berzigotti A, Calleja JL, Calvaruso V, Francque S, Schepis F, Procopet B, Albillos A, Rautou PE, García-Pagán JC, Puente Á, Fortea JI, Reiberger T, Mandorfer M; SSM-100Hz/ACLD Study Group; Baveno Cooperation.
Lancet Gastroenterol Hepatol. 2024 Dec;9(12):1111-1120.
PMID: 39326431

A social media listening study of patients' experiences relating to metabolic dysfunction-associated steatotic liver disease: The LISTEN-MASLD study.
Lazarus JV, Alazawi W, Basuroy R, Castera L, Estulin D, Koulla Y, Prasad P, Romero-Gomez M, Takahashi H, Wong VW, Schattenberg JM.
Ann Hepatol. 2024 Dec 2;30(1):101741.
PMID: 39631461

Loneliness and social anxiety in the general population over time - results of a cross-lagged panel analysis.
Reinwarth AC, Beutel ME, Schmidt P, Wild PS, Münzel T, König J, Konstantinides SV, Schattenberg JM, Lackner KJ, Schuster AK, Tüscher O, Geschke K.
Psychol Med. 2024 Dec 27:1-10.
PMID: 39726175

Change in Systemic Medication and its Influence on Intraocular Pressure - Results From the Gutenberg Health Study.
Laspas P, Hartmann A, Scholz I, Hoffmann EM, Khawaja AP, Lackner KJ, Münzel T, Kerahrodi JG, Schmidtmann I, Tüscher O, Schattenberg JM, Pfeiffer N, Konstantinides S, Wild PS, Schuster AK.
Invest Ophthalmol Vis Sci. 2024 Dec 2;65(14):4.
PMID: 39625443

Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort.
Wiegand J, Franke A, Müller T, Stein K, Bantel H, Günther R, Denk G, Reuken PA, Schattenberg JM, Naumann U, Böttler T, Weber A, Zeuzem S, Hinz M, Greinert R, Berg C, Wissniowski TT, Simon KG, Trebicka J, Behrens R, Grümmer H, Hofmann WP, Dikopoulos N, Sarrazin C, Roeb E, Kremer AE, Muche M, Ringelhan M, Teufel A, Michl P, Keitel V, Marquardt JU, Kautz A, Tacke F, Piotrowski K, Köppe-Bauernfeind N, Trautwein C, Berg T.
Z Gastroenterol. 2024 Nov;62(11):1931-1942.
PMID: 39227008

Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021.
Feng G, Targher G, Byrne CD, Yilmaz Y, Wai-Sun Wong V, Adithya Lesmana CR, Adams LA, Boursier J, Papatheodoridis G, El-Kassas M, Méndez-Sánchez N, Sookoian S, Castera L, Chan WK, Ye F, Treeprasertsuk S, Cortez-Pinto H, Yu HH, Kim W, Romero-Gómez M, Nakajima A, Win KM, Kim SU, Holleboom AG, Sebastiani G, Ocama P, Ryan JD, Lupșor-Platon M, Ghazinyan H, Al-Mahtab M, Hamid S, Perera N, Alswat KA, Pan Q, Long MT, Isakov V, Mi M, Arrese M, Sanyal AJ, Sarin SK, Leite NC, Valenti L, Newsome PN, Hagström H, Petta S, Yki-Järvinen H, Schattenberg JM, Castellanos Fernández MI, Leclercq IA, Aghayeva G, Elzouki AN, Tumi A, Sharara AI, Labidi A, Sanai FM, Matar K, Al-Mattooq M, Akroush MW, Benazzouz M, Debzi N, Alkhatry M, Barakat S, Al-Busafi SA, Rwegasha J, Yang W, Adwoa A, Opio CK, Sotoudeheian M, Wong YJ, George J, Zheng MH.
JHEP Rep. 2024 Nov 14;7(3):101271.
PMID: 39980749

Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis.
Lawitz EJ, Fraessdorf M, Neff GW, Schattenberg JM, Noureddin M, Alkhouri N, Schmid B, Andrews CP, Takács I, Hussain SA, Fenske WK, Gane EJ, Hosseini-Tabatabaei A, Sanyal AJ, Mazo DF, Younes R; NCT05296733 Investigators.
J Hepatol. 2024 Nov;81(5):837-846.
PMID: 38857788 

Serum protein risk stratification score for diagnostic evaluation of metabolic dysfunction-associated steatohepatitis.
Lai M, Dillon ST, Gu X, Morhardt TL, Xu Y, Chan NY, Xiong B, Can H, Ngo LH, Jin L, Zhang X, Moreira CC, Leite NC, Villela-Nogueira CA, Otu HH, Schattenberg JM, Schuppan D, Afdhal NH, Libermann TA.
Hepatol Commun. 2024 Nov 29;8(12):e0586.
PMID: 39621304

Blocking interleukin-1 receptor type 1 (IL-1R1) signaling in hepatocytes slows down diethylnitrosamine-induced liver tumor growth in obese mice.
Gehrke N, Hofmann LJ, Straub BK, Ridder DA, Waisman A, Kaps L, Galle PR, Schattenberg JM.
Hepatol Commun. 2024 Nov 29;8(12):e0568.
PMID: 39621069

Clinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.
Boeckmans J, Prochaska JH, Gieswinkel A, Böhm M, Wild PS, Schattenberg JM.
Lancet Reg Health Eur. 2024 Nov 30;48:101153.
PMID: 39687670

[Acute abdominal pain with surprising etiology-rare complication of a common disease].
Grotemeyer K, Motronea R, Schattenberg JM.
Inn Med (Heidelb). 2024 Oct 24.
PMID: 39446220

Assessment of psychological resilience in a large cohort of the general population: Validation and norm values of the RS-5.
Reinwarth AC, Hahad O, Ghaemi Kerahrodi J, Brähler E, Lieb K, Gilan D, Zahn D, Chalabi J, Schuster AK, Schepers M, Lackner KJ, Schattenberg JM, Ruf W, Wild PS, Daiber A, Michal M, Beutel ME, Münzel T.
PLoS One. 2024 Oct 11;19(10):e0309197
PMID: 39392830

Multicompartment Polyion Complex Micelles Based on Triblock Polypept(o)ides Mediate Efficient siRNA Delivery to Cancer-Associated Fibroblasts for Antistromal Therapy of Hepatocellular Carcinoma.
Schneider P, Zhang H, Simic L, Dai Z, Schrörs B, Akilli-Öztürk Ö, Lin J, Durak F, Schunke J, Bolduan V, Bogaert B, Schwiertz D, Schäfer G, Bros M, Grabbe S, Schattenberg JM, Raemdonck K, Koynov K, Diken M, Kaps L, Barz M.
Adv Mater. 2024 Oct;36(41):e2404784.
PMID: 38958110

acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study.
Feng G, Mózes FE, Ji D, Treeprasertsuk S, Okanoue T, Shima T, Liang H, Tsochatzis E, Chen J, Schattenberg JM, Labenz C, Mahadeva S, Chan WK, Chi X, Delamarre A, de Lédinghen V, Petta S, Bugianesi E, Hagström H, Boursier J, Calleja JL, Goh GB, Gallego-Durán R, Sanyal AJ, Fan JG, Castéra L, Lai M, Harrison SA, Romero-Gomez M, Kim SU, Zhu Y, Ooi G, Shi J, Yoneda M, Nakajima A, Zhang J, Lupsor-Platon M, Zhong B, Cobbold JFL, Ye CY, Eddowes PJ, Newsome P, Li J, George J, He F, Song MJ, Tang H, Fan Y, Jia J, Xu L, Lin S, Li Y, Lu Z, Nan Y, Niu J, Yan X, Zhou Y, Liu C, Deng H, Ye Q, Zeng QL, Li L, Wang J, Yang S, Lin H, Lee HW, Yip TC, Fournier-Poizat C, Wong GL, Pennisi G, Armandi A, Liu WY, Shang Y, de Saint-Loup M, Llop E, Teh KKJ, Lara-Romero C, Asgharpour A, Mahgoub S, Chan MS, Canivet CM, Ji F, Xin Y, Chai J, Dong Z, Targher G, Byrne CD, He N, Mi M, Ye F, Wong VW, Pavlides M, Zheng MH.
Clin Gastroenterol Hepatol. 2024 Oct 2:S1542-3565(24)00863-2.
PMID: 39362618

Decoding the diagnostic and therapeutic potential of microbiota using pan-body pan-disease microbiomics.
Schmartz GP, Rehner J, Gund MP, Keller V, Molano LG, Rupf S, Hannig M, Berger T, Flockerzi E, Seitz B, Fleser S, Schmitt-Grohé S, Kalefack S, Zemlin M, Kunz M, Götzinger F, Gevaerd C, Vogt T, Reichrath J, Diehl L, Hecksteden A, Meyer T, Herr C, Gurevich A, Krug D, Hegemann J, Bozhueyuek K, Gulder TAM, Fu C, Beemelmanns C, Schattenberg JM, Kalinina OV, Becker A, Unger M, Ludwig N, Seibert M, Stein ML, Hanna NL, Martin MC, Mahfoud F, Krawczyk M, Becker SL, Müller R, Bals R, Keller A.
Nat Commun. 2024 Sep 26;15(1):8261.
PMID: 39327438

Impairment of health-related quality of life among people with type 2 diabetes and advanced liver fibrosis.
Michel M, Funuyet-Salas J, Doll M, Alqahtani SA, Armandi A, Labenz C, Galle PR, Schattenberg JM.
Sci Rep. 2024 Sep 17;14(1):21650.
PMID: 39289410

Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease.
Vanderschueren E, Armandi A, Kwanten W, Cassiman D, Francque S, Schattenberg JM, Laleman W.
Am J Gastroenterol. 2024 Aug 1;119(8):1515-1524.
PMID: 38502095

Change of self-rated physical health predicts mortality in aging individuals: results of a population-based cohort study.
Reinwarth AC, Wicke FS, Rückert KK, Schattenberg JM, Tüscher O, Wild PS, Münzel T, König J, Lackner KJ, Pfeiffer N, Beutel ME.
Arch Public Health. 2024 Aug 23;82(1):130.
PMID: 39180092

Letter: Breaking new ground-Understanding the role of ATI-free diet in managing MASLD-Authors' reply.
Armandi A, Schuppan D, Schattenberg JM.
Aliment Pharmacol Ther. 2024 Jul;60(2):304-305.
PMID: 38860612

Inflammation in liver fibrosis and atrial fibrillation: A prospective population-based proteomic study.
Boeckmans J, Michel M, Gieswinkel A, Tüscher O, Konstantinides SV, König J, Münzel T, Lackner KJ, Kerahrodi JG, Schuster AK, Wild PS, Galle PR, Schattenberg JM.
JHEP Rep. 2024 Jul 18;6(10):101171.
PMID: 39380717

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.
Sanyal AJ, Bedossa P, Fraessdorf M, Neff GW, Lawitz E, Bugianesi E, Anstee QM, Hussain SA, Newsome PN, Ratziu V, Hosseini-Tabatabaei A, Schattenberg JM, Noureddin M, Alkhouri N, Younes R; 1404-0043 Trial Investigators.
N Engl J Med. 2024 Jul 25;391(4):311-319.
PMID: 38847460

Steatotische Lebererkrankung mit metabolischer Funktionsstörung – die neue Nomenklatur zur Fettleber im deutschen Kontext.
Schattenberg JM, Tacke F.
Z Gastroenterol. 2024 Jul;62(7):1074-1076.
PMID: 38976983

Amendment „Neue Nomenklatur zur MASLD (Metabolic Dysfunction Associated Steatotic Liver Disease; metabolische Dysfunktion assoziierte steatotische Lebererkrankung)“ zur S2k-Leitlinie „Nicht-alkoholische Fettlebererkrankung“ (v.2.0/April 2022) der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS).
Roeb E, Canbay A, Bantel H, Bojunga J, de Laffolie J, Demir M, Denzer UW, Geier A, Hofmann WP, Hudert C, Karlas T, Krawczyk M, Longerich T, Lüdde T, Roden M, Schattenberg JM, Sterneck M, Tannapfel A, Lorenz P, Tacke F; Collaborators.
Z Gastroenterol. 2024 Jul;62(7):1077-1087.
PMID: 38976985

The sclerotic component of metabolic syndrome: Fibroblast activities may be the central common denominator driving organ function loss and death.
Reese-Petersen AL, Holm Nielsen S, Bülow Sand JM, Schattenberg JM, Bugianesi E, Karsdal MA.
Diabetes Obes Metab. 2024 Jul;26(7):2554-2566.
PMID: 38699780

Lower Incidence of HCC and Other Major Adverse Liver Outcomes in People Living With HIV and Chronic Liver Disease.
Michel M, Hagström H, Widman L, Nowak P, Shang Y, Schattenberg JM, Wester A.
Gastro Hep Adv. 2024 Jun 4;3(6):783-792.
PMID: 39280909

Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosis.
Schleicher EM, Kaps L, Schattenberg JM, Galle PR, Wörns MA, Gairing SJ, Labenz C.
Dig Liver Dis. 2024 Jun;56(6):1046-1053.
PMID: 38105147

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD).
Vacca M, Kamzolas I, Harder LM, Oakley F, Trautwein C, Hatting M, Ross T, Bernardo B, Oldenburger A, Hjuler ST, Ksiazek I, Lindén D, Schuppan D, Rodriguez-Cuenca S, Tonini MM, Castañeda TR, Kannt A, Rodrigues CMP, Cockell S, Govaere O, Daly AK, Allison M, Honnens de Lichtenberg K, Kim YO, Lindblom A, Oldham S, Andréasson AC, Schlerman F, Marioneaux J, Sanyal A, Afonso MB, Younes R, Amano Y, Friedman SL, Wang S, Bhattacharya D, Simon E, Paradis V, Burt A, Grypari IM, Davies S, Driessen A, Yashiro H, Pors S, Worm Andersen M, Feigh M, Yunis C, Bedossa P, Stewart M, Cater HL, Wells S, Schattenberg JM, Anstee QM; LITMUS Investigators; Tiniakos D, Perfield JW, Petsalaki E, Davidsen P, Vidal-Puig A.
Nat Metab. 2024 Jun;6(6):1178-1196.
PMID: 38867022

Editorial: Can dietary gluten restriction improve hepatic steatosis? Authors' reply.
Armandi A, Schuppan D, Schattenberg JM.
Aliment Pharmacol Ther. 2024 Jun;59(12):1622-1623.
PMID: 38709121

Bi-Gaussian analysis reveals distinct education-related alterations in spherical equivalent and axial length-results from the Gutenberg Health Study.
Hartmann A, Grabitz SD, Wagner FM, Wild PS, Müller-Nurasyid M, Lackner KJ, Beutel ME, Münzel T, Tüscher O, Schattenberg JM, Pfeiffer N, Schuster AK.
Graefes Arch Clin Exp Ophthalmol. 2024 Jun;262(6):1819-1828.
PMID: 38446204

Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients.
Schemmerer M, Bock HH, Schattenberg JM, Huber S, Polywka S, Mader M, Lohse AW, Todt D, Steinmann E, Wenzel JJ, Horvatits T, Pischke S.
J Med Virol. 2024 Jun;96(6):e29735.
MID: 38864313

Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study.
Shaikh A, Pedra G, Ruiz-Casas L, Franks B, Dhillon H, Fernandes JDDR, Mangla KK, Augusto M, Romero-Gómez M, Schattenberg JM.
Gastroenterol Hepatol. 2024 May;47(5):463-472.
PMID: 37890583

Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept study.
Armandi A, Bespaljko H, Mang A, Huber Y, Michel M, Labenz C, Galle PR, Neerukonda M, Bugianesi E, Schuppan D, Schattenberg JM.
Aliment Pharmacol Ther. 2024 May;59(10):1212-1222.
PMID: 38462919

Elevated Colon Cancer Rates Linked to Prior Appendicitis: A Retrospective Cohort Study Based on Data from German General Practices.
Steffes S, Kostev K, Schattenberg JM, Heinzow HS, Maschmeier M.
J Clin Med. 2024 Apr 18;13(8):2342.
PMID: 38673618

Accuracy, Reliability, and Comprehensibility of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver Disease.
Pugliese N, Wai-Sun Wong V, Schattenberg JM, Romero-Gomez M, Sebastiani G; NAFLD Expert Chatbot Working Group; Aghemo A.
Clin Gastroenterol Hepatol. 2024 Apr;22(4):886-889.e5.
PMID: 37716618

Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.
Armandi A, Sanavia T, Younes R, Caviglia GP, Rosso C, Govaere O, Liguori A, Francione P, Gallego-Duràn R, Ampuero J, Pennisi G, Aller R, Tiniakos D, Burt A, David E, Vecchio F, Maggioni M, Cabibi D, McLeod D, Pareja MJ, Zaki MYW, Grieco A, Stål P, Kechagias S, Fracanzani AL, Valenti L, Miele L, Fariselli P, Eslam M, Petta S, Hagström H, George J, Schattenberg JM, Romero-Gómez M, Anstee QM, Bugianesi E.
Gut. 2024 Apr 5;73(5):825-834.
PMID: 38199805

Inequities in primary liver cancer in Europe: The state of play.
Kondili LA, Lazarus JV, Jepsen P, Murray F, Schattenberg JM, Korenjak M, Craxì L, Buti M.
J Hepatol. 2024 Apr;80(4):645-660.
PMID: 38237866

The ABCG8 polymorphism increases the risk of gallbladder cancer in the general population and gallstones in obese patients from Poland.
Krupa L, Kalinowski P, Ligocka J, Dauer M, Jankowski K, Gozdowska J, Kruk B, Milkiewicz P, Zieniewicz K, Krawczyk M, Weber SN, Lammert F, Krawczyk M.
Eur J Clin Invest. 2024 Apr 14:e14213.
PMID: 38616505

Development and validation of a multivariable risk prediction model for hepatic steatosis in patients with HIV infection.
Wirth M, Ruckes C, Michel M, Schattenberg JM.
AIDS. 2024 Mar 15;38(4):447-454.
PMID: 37924505

Skin advanced glycation end-products as indicators of the metabolic profile in diabetes mellitus: correlations with glycemic control, liver phenotypes and metabolic biomarkers.
Christidis G, Küppers F, Karatayli SC, Karatayli E, Weber SN, Lammert F, Krawczyk M.
BMC Endocr Disord. 2024 Mar 5;24(1):319.
PMID: 38443880

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
Younossi ZM, Alqahtani SA, Alswat K, Yilmaz Y, Keklikkiran C, Funuyet-Salas J, Romero-Gómez M, Fan JG, Zheng MH, El-Kassas M, Castera L, Liu CJ, Wai-Sun Wong V, Zelber-Sagi S, Allen AM, Lam B, Treeprasertsuk S, Hameed S, Takahashi H, Kawaguchi T, Schattenberg JM, Duseja A, Newsome PN, Francque S, Spearman CW, Castellanos Fernández MI, Burra P, Roberts SK, Chan WK, Arrese M, Silva M, Rinella M, Singal AK, Gordon S, Fuchs M, Alkhouri N, Cusi K, Loomba R, Ranagan J, Eskridge W, Kautz A, Ong JP, Kugelmas M, Eguchi Y, Diago M, Yu ML, Gerber L, Fornaresio L, Nader F, Henry L, Racila A, Golabi P, Stepanova M, Carrieri P, Lazarus JV; Global NASH Council.
J Hepatol. 2024 Mar;80(3):419-430.
PMID: 37984709

The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease.
Younossi ZM, AlQahtani SA, Funuyet-Salas J, Romero-Gómez M, Yilmaz Y, Keklikkiran C, Alswat K, Yu ML, Liu CJ, Fan JG, Zheng MH, Burra P, Francque SM, Castera L, Schattenberg JM, Newsome PN, Allen AM, El-Kassas M, Treeprasertsuk S, Hameed S, Wai-Sun Wong V, Zelber-Sagi S, Takahashi H, Kawaguchi T, Castellanos Fernández MI, Duseja A, Arrese M, Rinella M, Singal AK, Gordon SC, Fuchs M, Eskridge W, Alkhouri N, Cusi K, Loomba R, Ranagan J, Kautz A, Ong JP, Kugelmas M, Eguchi Y, Diago M, Gerber L, Lam B, Fornaresio L, Nader F, Spearman CW, Roberts SK, Chan WK, Silva M, Racila A, Golabi P, Ananchuensook P, Henry L, Stepanova M, Carrieri P, Lazarus JV; Global NASH Council.
JHEP Rep. 2024 Mar 12;6(7):101066.
PMID: 39022387

Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients.
Dietz J, Graf C, Berg CP, Port K, Deterding K, Buggisch P, Peiffer KH, Vermehren J, Dultz G, Geier A, Reiter FP, Bruns T, Schattenberg JM, Durmashkina E, Gustot T, Moreno C, Trauth J, Discher T, Fischer J, Berg T, Kremer AE, Müllhaupt B, Zeuzem S, Sarrazin C; European HCV Resistance Study Group.
JHEP Rep. 2024 Mar 25;6(7):101072.
PMID: 39006503

Noise annoyance and cardiovascular disease risk: results from a 10-year follow-up study.
Hahad O, Gilan D, Michal M, Tüscher O, Chalabi J, Schuster AK, Keller K, Hobohm L, Schmitt VH, König J, Lackner KJ, Wild P, Schattenberg JM, Daiber A, Münzel T.
Sci Rep. 2024 Mar 7;14(1):5619.
PMID: 38454061

Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes.
Michel M, Doll M, Albert N, Morgenstern M, Behr A, Maxeiner S, Labenz C, Galle PR, Schattenberg JM.
United European Gastroenterol J. 2024 Feb;12(1):11-21.
PMID: 38206118

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators.
N Engl J Med. 2024 Feb 8;390(6):497-509
PMID: 38324483

A global action agenda for turning the tide on fatty liver disease.
Lazarus JV, Mark HE, Allen AM, Arab JP, Carrieri P, Noureddin M, Alazawi W, Alkhouri N, Alqahtani SA, Anstee QM, Arrese M, Bataller R, Berg T, Brennan PN, Burra P, Castro-Narro GE, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque SM, Gastaldelli A, Hagström H, Huang TTK, Ivancovsky Wajcman D, Kautz A, Kopka CJ, Krag A, Newsome PN, Rinella ME, Romero D, Sarin SK, Silva M, Spearman CW, Terrault NA, Tsochatzis EA, Valenti L, Villota-Rivas M, Zelber-Sagi S, Schattenberg JM, Wong VW, Younossi ZM; Healthy Livers, Healthy Lives Collaborators.
Hepatology. 2024 Feb 1;79(2):502-523.
PMID: 37540183

The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement.
Hagström H, Adams LA, Allen AM, Byrne CD, Chang Y, Duseja A, Grønbæk H, Ismail MH, Jepsen P, Kanwal F, Kramer J, Loomba R, Mark HE, Newsome PN, Rinella ME, Rowe IA, Ryu S, Sanyal A, Schattenberg JM, Serper M, Sheron N, Simon TG, Spearman CW, Tapper EB, Villota-Rivas M, Wild SH, Wong VW, Yilmaz Y, Zelber-Sagi S, Åberg F, Lazarus JV.
Hepatol Commun. 2024 Feb 3;8(2):e0386.
PMID: 38315102

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, Invernizzi P, Jones D, Kruger FC, Lawitz E, Mayo MJ, Shiffman ML, Swain MG, Valera JM, Vargas V, Vierling JM, Villamil A, Addy C, Dietrich J, Germain JM, Mazain S, Rafailovic D, Taddé B, Miller B, Shu J, Zein CO, Schattenberg JM; ELATIVE Study Investigators’ Group; ELATIVE Study Investigators' Group.
N Engl J Med. 2024 Feb 29;390(9):795-805.
PMID: 37962077

Liver stiffness as a cornerstone in heart disease risk assessment.
Boeckmans J, Sandrin L, Knackstedt C, Schattenberg JM.
Liver Int. 2024 Feb;44(2):344-356.
PMID: 38014628

Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information.
McTeer M, Applegate D, Mesenbrink P, Ratziu V, Schattenberg JM, Bugianesi E, Geier A, Romero Gomez M, Dufour JF, Ekstedt M, Francque S, Yki-Jarvinen H, Allison M, Valenti L, Miele L, Pavlides M, Cobbold J, Papatheodoridis G, Holleboom AG, Tiniakos D, Brass C, Anstee QM, Missier P; LITMUS Consortium investigators.
PLoS One. 2024 Feb 29;19(2):e0299487.
PMID: 38421999

Implementation of a liver health check in people with type 2 diabetes.
Abeysekera KWM, Valenti L, Younossi Z, Dillon JF, Allen AM, Nourredin M, Rinella ME, Tacke F, Francque S, Ginès P, Thiele M, Newsome PN, Guha IN, Eslam M, Schattenberg JM, Alqahtani SA, Arrese M, Berzigotti A, Holleboom AG, Caussy C, Cusi K, Roden M, Hagström H, Wong VW, Mallet V, Castera L, Lazarus JV, Tsochatzis EA.
Lancet Gastroenterol Hepatol. 2024 Jan;9(1):83-91.
PMID: 38070521

Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis.
Harrison SA, Ratziu V, Anstee QM, Noureddin M, Sanyal AJ, Schattenberg JM, Bedossa P, Bashir MR, Schneider D, Taub R, Bansal M, Kowdley KV, Younossi ZM, Loomba R.
Aliment Pharmacol Ther. 2024 Jan;59(1):51-63.
PMID: 37786277

Editorial: Does knowledge about liver disease enhance adherence to lifestyle recommendations?
Michel M, Schattenberg JM.
Aliment Pharmacol Ther. 2024 Jan;59(2):283-284.
PMID: 38153277

Change of Intraocular Pressure Over 5 Years and its Relationship to Cardiovascular Parameters: Results From the Gutenberg Health Study.
Hartmann A, Scholz I, Hoffmann EM, Strzalkowska A, Lackner KJ, Münzel T, Wicke FS, Schmidtmann I, Tüscher O, Schattenberg JM, Konstantinides S, Wild PS, Pfeiffer N, Schuster AK.
Invest Ophthalmol Vis Sci. 2024 Jan 2;65(1):12.
PMID: 38175640

ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort.
Kruk B, Liebe R, Weber SN, Milkiewicz P, Krawczyk M.
J Hepatol. 2023 Nov 28:S0168-8278(23)05290-X.
PMID: 38036008

Identification of Fast Progressors Among Patients With Nonalcoholic Steatohepatitis Using Machine Learning.
Schattenberg JM, Balp MM, Reinhart B, Porwal S, Tietz A, Pedrosa MC, Docherty M.
Gastro Hep Adv. 2023 Sep 15;3(1):101-108.
PMID: 39132186

Influence of NOD2 risk variants on hepatic encephalopathy and association with inflammation, bacterial translocation and immune activation.
Ripoll C, Greinert R, Reuken P, Reichert MC, Weber SN, Hupfer Y, Staltner R, Meier Clinien M, Lammert F, Bruns T, Zipprich A.
Liver Int. 2023 Aug;43(8):1793-1802.
PMID: 37249050

Effects of MBOAT7 polymorphism and steatosis on liver function assessed by methacetin breath test.
Di Ciaula A, Bonfrate L, Shanmugam H, Weber SN, Krawczyk M, Portincasa P.
Eur J Clin Invest. 2023 Aug;53(8):e14003.
PMID: 37029745

Liver phenotypes in PCOS: Analysis of exogenous and inherited risk factors for liver injury in two European cohorts.
Smyk W, Papapostoli I, Żorniak M, Sklavounos P, Blukacz Ł, Madej P, Koutsou A, Weber SN, Friesenhahn-Ochs B, Cebula M, Bosowska J, Solomayer EF, Hartleb M, Milkiewicz P, Lammert F, Stokes CS, Krawczyk M.
Liver Int. 2023 May;43(5):1080-1088.
PMID: 36683562

Altered Expression of Antimicrobial Peptides in the Upper Gastrointestinal Tract of Patients with Diabetes Mellitus.
Linn O, Menges B, Lammert F, Weber SN, Krawczyk M.
Nutrients. 2023 Feb 2;15(3):754.
PMID: 36771460

MTARC1 and HSD17B13 Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery.
Kalinowski P, Smyk W, Nowosad M, Paluszkiewicz R, Michałowski Ł, Ziarkiewicz-Wróblewska B, Weber SN, Milkiewicz P, Lammert F, Zieniewicz K, Krawczyk M.
Int J Mol Sci. 2022 Dec 13;23(24):15825.
PMID: 36555467

The rs12532734 Polymorphism Near the Solute Carrier 26A3 Gene Locus Is Associated With Gallstone Disease in Children.
Krawczyk M, Niewiadomska O, Jankowska I, Jankowski K, Świderska J, Lebensztejn D, Więcek S, Gozdowska J, Kułaga Z, Weber SN, Lammert F, Socha P.
J Pediatr Gastroenterol Nutr. 2022 Dec 1;75(6):692-694.
PMID: 36084219

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.
Graupera I, Thiele M, Ma AT, Serra-Burriel M, Pich J, Fabrellas N, Caballeria L, de Knegt RJ, Grgurevic I, Reichert M, Roulot D, Schattenberg JM, Pericas JM, Angeli P, Tsochatzis EA, Guha IN, Garcia-Retortillo M, Morillas RM, Hernández R, Hoyo J, Fuentes M, Madir A, Juanola A, Soria A, Juan M, Carol M, Diaz A, Detlefsen S, Toran P, Pera G, Fournier C, Llorca A, Newsome PN, Manns M, de Koning HJ, Serra-Burriel F, Cucchietti F, Arslanow A, Korenjak M, van Kleef L, Falcó JL, Kamath PS, Karlsen TH, Castera L, Lammert F, Krag A, Ginès P; LiverScreen Consortium investigators.
BMC Public Health. 2022 Jul 19;22(1):1385.
PMID: 35854275

Common variant p.D19H of the hepatobiliary sterol transporter ABCG8 increases the risk of gallstones in children.
Krawczyk M, Niewiadomska O, Jankowska I, Jankowski K, Więckowski S, Lebensztejn D, Więcek S, Gozdowska J, Kułaga Z, Weber SN, Lütjohann D, Lammert F, Socha P.
Liver Int. 2022 Jul;42(7):1585-1592.
PMID: 35129276

pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages.
Kaps L, Huppertsberg A, Choteschovsky N, Klefenz A, Durak F, Schrörs B, Diken M, Eichler E, Rosigkeit S, Schmitt S, Leps C, Schulze A, Foerster F, Bockamp E, De Geest BG, Koynov K, Räder HJ, Tenzer S, Marini F, Schuppan D, Nuhn L.
Proc Natl Acad Sci U S A. 2022 Mar 22;119(12):e2122310119.
PMID: 35290110

Intrahepatic cholestasis of pregnancy in conjunction with a frameshift deletion in FGFR4.
Batool SS, Dauer M, Weber SN, Liebe R, Lammert F, Reichert MC.
Clin Res Hepatol Gastroenterol. 2022 Mar;46(3):101800
PMID: 34517148

MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis.
Janik MK, Smyk W, Kruk B, Szczepankiewicz B, Górnicka B, Lebiedzińska-Arciszewska M, Potes Y, Simões ICM, Weber SN, Lammert F, Więckowski MR, Milkiewicz P, Krawczyk M.
Sci Rep. 2021 Dec 23;11(1):24407.
PMID: 34949757

Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
Christidis G, Karatayli E, Hall RA, Weber SN, Reichert MC, Hohl M, Qiao S, Boehm U, Lütjohann D, Lammert F, Karatayli SC.
Int J Mol Sci. 2021 Jul 23;22(15):7898.
PMID: 34360670

Effects of blocking chemokine receptor CCR1 with BX471 in two models of fibrosis prevention and rescue in mice.
Weber SN, Nowak I, Grünhage F, Lammert F.
Biochem Biophys Rep. 2021 Jul 15;27:101077.
PMID: 34337167

Complement in Acute Liver Failure: The Right Timing to Give a Sincere Compliment.
Weber SN, Lammert F.
Cell Mol Gastroenterol Hepatol. 2021;11(5):1546-1547.
PMID: 33757763

Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality.
Schunk SJ, Kleber ME, März W, Pang S, Zewinger S, Triem S, Ege P, Reichert MC, Krawczyk M, Weber SN, Jaumann I, Schmit D, Sarakpi T, Wagenpfeil S, Kramann R, Boerwinkle E, Ballantyne CM, Grove ML, Tragante V, Pilbrow AP, Richards AM, Cameron VA, Doughty RN, Dubé MP, Tardif JC, Feroz-Zada Y, Sun M, Liu C, Ko YA, Quyyumi AA, Hartiala JA, Tang WHW, Hazen SL, Allayee H, McDonough CW, Gong Y, Cooper-DeHoff RM, Johnson JA, Scholz M, Teren A, Burkhardt R, Martinsson A, Smith JG, Wallentin L, James SK, Eriksson N, White H, Held C, Waterworth D, Trompet S, Jukema JW, Ford I, Stott DJ, Sattar N, Cresci S, Spertus JA, Campbell H, Tierling S, Walter J, Ampofo E, Niemeyer BA, Lipp P, Schunkert H, Böhm M, Koenig W, Fliser D, Laufs U, Speer T; eQTLGen consortium; BIOS consortium.
Eur Heart J. 2021 May 7;42(18):1742-1756.
PMID: 33748830

Long-Term Colestyramine Treatment Prevents Cholestatic Attacks in Refractory Benign Recurrent Intrahepatic Cholestasis Type 1 Disease.
Koukoulioti E, Ziagaki A, Weber SN, Lammert F, Berg T.
Hepatology. 2021 Jul;74(1):522-524.
PMID: 33277690

Acute Pancreatitis in the Setting of Hepatitis E Virus (Genotype 3) Infection and Compound CLDN2-PRSS1 Risk Variants.
Lehmann J, Muresan S, Weber SN, Lammert F, Krawczyk M.
Pancreas. 2020 Oct;49(9):e91-e93.
PMID: 33003098

Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers.
Kaps L, Schuppan D.
Cells. 2020 Sep 3;9(9):2027.
PMID: 32899119

Genetic variant c.711A>T in the hepatobiliary phospholipid transporter ABCB4 is associated with significant liver fibrosis.
Smyk W, Weber SN, Hall R, Gruenhage F, Lammert F, Krawczyk M.
J Physiol Pharmacol. 2020 Jun;71(3).
PMID: 32991311

Common variation in FAM155A is associated with diverticulitis but not diverticulosis.
Reichert MC, Kupcinskas J, Schulz A, Schramm C, Weber SN, Krawczyk M, Jüngst C, Casper M, Grünhage F, Appenrodt B, Zimmer V, Tamelis A, Lukosiene JI, Pauziene N, Kiudelis G, Jonaitis L, Goeser T, Malinowski M, Glanemann M, Kupcinskas L, Lammert F.
Sci Rep. 2020 Feb 3;10(1):1658.
PMID: 32015353

Risk of chemotherapy-associated liver injury (CALI) in PNPLA3 p.148M allele carriers: Preliminary results of a transient elastography-based study.
Casper M, Zimmermann S, Weber SN, Arslanow A, Lammert F, Krawczyk M.
Dig Liver Dis. 2020 Jan;52(1):102-106.
PMID: 31669075

SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles.
Leber N, Kaps L, Aslam M, Schupp J, Brose A, Schäffel D, Fischer K, Diken M, Strand D, Koynov K, Tuettenberg A, Nuhn L, Zentel R, Schuppan D.
J Control Release. 2017 Feb 28;248:10-23.
PMID: 27940184